The use of sodium-glucose cotransporter-2 (SGLT2) inhibitors in STEMI - Weekly Research Conference

Поделиться
HTML-код
  • Опубликовано: 3 дек 2024
  • Presenter: Michel Le May, MD
    Director, University of Ottawa Heart Institute Regional STEMI Program,
    University of Ottawa
    Professor, Faculty of Medicine,
    University of Ottawa

Комментарии •